Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem Sells 20,492 Shares

Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem sold 20,492 shares of the firm’s stock in a transaction on Monday, January 13th. The stock was sold at an average price of $0.81, for a total transaction of $16,598.52. Following the transaction, the general counsel now directly owns 205,028 shares in the company, valued at $166,072.68. The trade was a 9.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Outset Medical Stock Down 12.2 %

Shares of Outset Medical stock opened at $0.81 on Tuesday. Outset Medical, Inc. has a one year low of $0.44 and a one year high of $5.22. The company has a market cap of $42.44 million, a P/E ratio of -0.29 and a beta of 2.05. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49. The firm has a fifty day moving average of $1.01 and a two-hundred day moving average of $1.41.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in OM. GSA Capital Partners LLP boosted its holdings in Outset Medical by 924.7% in the 3rd quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after purchasing an additional 1,003,135 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Outset Medical by 118.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock valued at $5,925,000 after buying an additional 834,663 shares during the period. Millennium Management LLC grew its holdings in Outset Medical by 58.8% during the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after acquiring an additional 719,412 shares during the period. Marshall Wace LLP raised its position in Outset Medical by 487.8% in the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after acquiring an additional 260,740 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in Outset Medical in the second quarter worth $827,000.

Analysts Set New Price Targets

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 price target on shares of Outset Medical in a research report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.